The Severity Assessment Model for AECOPD With Combination of Disease and Syndrome

NCT06918353 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2025-04-11

No results posted yet for this study

Summary

The establishment of the AECOPD severity assessment model can quickly and accurately evaluate the condition, which is of great significance for standardizing diagnosis and treatment, improving efficacy, and improving prognosis. At the same time, it can provide ideas and methods for the research of disease assessment models in related fields.

Conditions

  • Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Interventions

DIAGNOSTIC_TEST

Diagnosis and Severity Grading of AECOPD Disease

Diagnosis and severity grading of AECOPD disease, as well as assessment of traditional Chinese medicine syndromes

Sponsors & Collaborators

  • The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

    collaborator OTHER
  • Henan Provincial People's Hospital

    collaborator OTHER
  • Third Affiliated Hospital of Henan University of Traditional Chinese Medicine

    collaborator OTHER
  • Jiangsu province hospital of TCM

    collaborator UNKNOWN
  • Qingdao Traditional Chinese Medicine Hospital(Qingdao Hiser Hospital)

    collaborator UNKNOWN
  • Xiangyang Traditional Chinese Medicine Hospital

    collaborator UNKNOWN
  • Yanshi People's Hospital of Luoyang City

    collaborator UNKNOWN
  • Shangcai County Traditional Chinese Medicine Hospital

    collaborator UNKNOWN
  • Henan University of Traditional Chinese Medicine

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06918353 on ClinicalTrials.gov